Program Overview (5 mins)
Key HIV Studies Influencing My Practice Following AIDS 2022 (25 mins)
- Summary of the most important HIV studies
- Key clinical practice recommendations
Question and Answer Session (15 mins)
*CCO is the exclusive official partner of the International AIDS Society for online scientific analysis of this conference.
Date / Time
Chloe Orkin, MBChB, FRCP, MD
Professor of HIV
Queen Mary, University of London
Lead for HIV Research
Barts Health NHS Trust
The Royal London Hospital
London, United Kingdom
David A. Wohl, MD
Professor of Medicine
School of Medicine
Site Leader, Global Infectious Diseases
Clinical Trials Unit
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
The goal of this activity is to improve learners’ knowledge and competence in integrating new data on HIV treatment and prevention into their current and future patient care strategies.
This program is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for patients with or at risk of HIV infection.
Upon completion of this activity, participants should be able to:
- Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents
- Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens
- Employ the latest scientific literature to develop and optimize effective HIV prevention strategies
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Designation of Credit
CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.
Continuing Pharmacy Education
CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-159-L02-P
Type of Activity: Knowledge
Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.